GBLX Share Price Performance
US$0.0005
-0.00 (-88.10%)
Price US$0.0005
Share Pricen/a
GB Sciences, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
GBLX Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
GB Sciences, Inc. Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- -0.0021
- 100.00%
- -1,085.52%
- -33.9%
About GBLX
- Founded
- n/a
- Employees
- 2
- CEO
- WebsiteView website
GB Sciences, Inc., a plant-based research and biopharmaceutical drug development company. The company offers cannabis inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson’s disease, neuropathic pain, chronic pain, cytokine release syndrome, stress/anxiety/depression, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. is based in Las Vegas, Nevada.
